>>132656
cont...
Other Recalls
Several weeks ago, the FDA announced that Marlex Pharmaceuticals voluntarily recalled one lot of 0.125-milligram Digoxin Tablets USP and one lot of 0.25-milligram Digoxin Tablets USP.
The reason why, according to the notice, is due to a "label mix-up," which could potentially lead to an overdose of the wrong medication. Weaker versions of the heart medication were placed into bottles of the stronger medication and vice versa.
"The mix-up in labels can cause either overdosing or underdosing in patients who unknowingly take the wrong dose," the notice said. "Patients who intend to take Digoxin Tablets USP ... would receive a super potent dose and can experience significant drug toxicity (mental disorientation, dizziness, blurred vision, memory loss and fainting) from the unintentional overdose."
"The product is used for the treatment of mild to moderate heart failure," it said. "Digoxin increases heart muscle contraction in pediatric patients with heart failure. Digoxin is indicated for the control of ventricular response rate in adult patients with chronic atrial fibrillation. The product is packaged as 100 tablets in white HDPE bottles and labeled as indicated below with NDC, lot and expiration date."
Around the same time, a separate FDA notice announced the recall of WEFUN capsules[dietary supplement] after the agency found the product was tainted with another drug, sildenafil. "FDA analysis has found the product to be tainted with sildenafil. Sildenafil is an ingredient known as a Phosphodiesterase Inhibitor (PDE-5) inhibitor found in FDA-approved products for the treatment of male erectile dysfunction. The presence of sildenafil in this product renders it an unapproved drug for which the safety and efficacy has not been established and, therefore, subject to recall," it said.
Several weeks ago, Glenmark Pharmaceuticals USA and Baxter Healthcare separately recalled drugs that are used to treat hypertension and cancer, respectively. Glenmark recalled 1,200 bottles of trandolapril and verapamil hydrochloride extended-release tablets for high blood pressure, while Baxter recalled 13,502 vials of bendamustine HCl injection, used to treat several types of cancer.

https://www.theepochtimes.com/health/fda-notice-blood-pressure-drugs-recalled-after-powerful-opioid-found-5505410?src_src=News&src_cmp=breaking-2023-10-07-2&cta_utm_source=News&est=PWX0vLmLv2D8IbOCdboxUAyP3QiL%2FBmPG7b6b%2Bx3ZTKAzZuk6wX%2B%2B%2BZa2P%2FxOxXkRLw%3D